ArticleThe Journal of clinical investigation2017

CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease.

Su Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.